Prudential Financial
BDSI

Prudential Financial’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Prudential Financial’s Portfolio BDSI Stock Details BDSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-56,745
Closed -$176K – 2744
2021
Q4 		$176K Buy
56,745
+42,627
+302% +$143K ﹤0.01% 2557
2021
Q3 		$51K Sell
14,118
-997
-7% -$3.76K ﹤0.01% 2551
2021
Q2 		$54K Buy
15,115
+2,678
+22% +$9.45K ﹤0.01% 2514
2021
Q1 		$49K Buy
12,437
+1,239
+11% +$5.12K ﹤0.01% 2458
2020
Q4 		$47K Hold
11,198
– – ﹤0.01% 2412
2020
Q3 		$42K Buy
11,198
+869
+8% +$3.7K ﹤0.01% 2396
2020
Q2 		$45K Sell
10,329
-19,100
-65% -$85.8K ﹤0.01% 2362
2020
Q1 		$112K Sell
29,429
-2,117
-7% -$10.4K ﹤0.01% 2261
2019
Q4 		$199K Buy
31,546
+21,281
+207% +$125K ﹤0.01% 2334
2019
Q3 		$43K Buy
+10,265
New +$43.8K ﹤0.01% 2386

Other funds holding BDSI

CAM
Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return
FCMT
Founders Capital Management (Texas) Houston, Texas $231M AUM 61.68% 1-Year Est. Return

Prudential Financial's BDSI Position: Q1 2022 in Review

Prudential Financial sold out of BioDelivery Sciences International, Inc. (BDSI) in Q1 2022, closing a stake of 56,745 shares — an estimated $176K sold.

Prudential Financial first reported a position in BDSI in Q3 2019 and held it in 10 quarters. The position peaked at $199K in Q4 2019. 2 funds tracked by Wall St. Rank hold BDSI as of Q1 2022.

  • Prudential Financial reported no remaining BioDelivery Sciences International, Inc. position as of Q1 2022 after selling out during the quarter.
  • Prudential Financial sold 56,745 BioDelivery Sciences International, Inc. shares in Q1 2022, an estimated $176K.
  • Prudential Financial first reported a position in BioDelivery Sciences International, Inc. in Q3 2019 and held it in 10 quarters.
  • Prudential Financial's BioDelivery Sciences International, Inc. position peaked at $199K in Q4 2019.
  • 2 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2022.

Based on Prudential Financial's 13F filing for Q1 2022, filed 13 May 2022.